Applied DNA Sciences (APDN) said Monday preclinical animal data published in a peer-reviewed publication backs the use of its LinearDNA platform to make...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
...
Applied DNA Sciences (APDN) said Wednesday an undisclosed New York City-based investment management firm awarded the company's Applied DNA Clinical Labs...
| Address | 50 Health Sciences Drive Stony Brook, New York 11790 |
| Phone | +1.631.240.8800 |
| Number of Employees | 59 |
| Recent SEC Filing | 05/12/2022 8-K |
| Chairman, President & Chief Executive Officer | James A. Hayward |
| Chief Operating Officer | Judy Murrah |
| Chief Financial Officer & Controller | Beth M. Jantzen |
| Associate Director-Production | Frank Cipriani |
| Price Open | $0.74 |
| Previous Close | $0.74 |
| 52 Week Range | $0.67 - 8.10 |
| Market Capitalization | $5.3 M |
| Shares Outstanding | 7.5 M |
| Sector | Health Technology |
| Industry | Biotechnology | Next Earnings Announcement | 08/11/2022 |
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
| Price / Earnings | N/A |
| Earnings per Share | -$1.88 |
| Beta vs. S&P 500 | N/A |
| Revenue | $3.9 M |
| Net Profit Margin | -95.93% |
| Return on Equity | -135.14% |
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |
